Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits

Pediatric Research

Volumn 60, Issue 1, 2006, Pages 65-70

  Brunelli, Luca ^a,b   Hamilton, Eric ^c   Davis, Jonathan M ^d   Koo, Hshi Chi ^d   Joseph, Ansamma ^d   Kazzaz, Jeffrey A ^d   Wolfson, Marla R ^c   Shaffer, Thomas H ^c,e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; CARBONYL DERIVATIVE; FLUORESCENT DYE; PERFLUORO COMPOUND; RECOMBINANT ENZYME; RECOMBINANT SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LOCALIZATION; HISTOLOGY; LUNG INJURY; LUNG LAVAGE; LUNG VENTILATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RABBIT; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL TRANSPORT; DRUG DELIVERY SYSTEMS; FLUOROCARBONS; LUNG; LUNG DISEASES; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PULMONARY GAS EXCHANGE; RABBITS; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE;

EID: 33748084401     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000219392.73509.70     Document Type: Article

References (42)

1. Frank L 1985 Effects of oxygen on the newborn. Fed Proc 44:2328-2333
2. Crapo JD, Oury T, Rabouille C, Slot JW, Chang LY 1992 Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci U S A 89:10405-10409
3. Weisiger RA, Fridovich I Superoxide dismutase: organelle specificity J Biol Chem 1973;248:3582-3592
4. Marklund SL 1982 Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 79:7634-7638
5. Wispe JR, Roberts RJ 1988 Bronchopulmonary Dysplasia. Blackwell Scientific, Cambridge, pp 103-116
6. Frank L, Price LT, Whitney PL 1996 Possible mechanism for late gestational development of the antioxidant enzymes in the fetal rat lung. Biol Neonate 70:116-127
7. Asikainen TM, Ravio KO, Saksela M, Kinnula VL 1998 Expression and developmental profile of antioxidant enzymes in human lung and liver. Am J Resp Cell Mol Biol 19:942-949
8. McElroy MC, Postle AD, Kelly FJ 1992 Catalase, superoxide dismutase and glutathione peroxidase activities of lung and liver during human development. Biochim Biophys Acta 1117:153-158
9. Sosenko IR, Chen Y, Price LT, Frank L 1995 Failure of premature rabbits to increase lung antioxidant enzyme activities after hyperoxic exposure: antioxidant enzyme gene expression and pharmacologic intervention with endotoxin and dexamethasone. Pediatr Res 37:469-475
10. Freeman BA, Young SL, Crapo JD 1983 Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen toxicity. J Biol Chem 258:12534-12542
11. Walther FJ, Gidding CE, Kuipers IM, Willebrand D, Bevers EM, Abuchowski A, Viau AT 1986 Prevention of oxygen toxicity with superoxide dismutase and catalase in premature lambs. J Free Radic Biol Med 2:289-293
12. Rosenfeld WN, Davis JM, Parton L, Richter SE, Price A, Flaster E, Kassem N 1996 Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 97:811-817
13. Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S 1997 Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 100:24-30
14. Davis JM, Richter SE, Biswas S, Rosenfeld WN, Parton L, Gewolb IH, Parad R, Carlo W, Couser RJ, Baumgart S, Atluru V, Salerno L, Kassem N 2000 Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase. J Perinatol 20:213-216
15. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W North American Recombinant Human CuZnSOD Study Group 2003 Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 111:469-476
16. Shaffer TH, Wolfson MR, Clark LC 1992 Liquid ventilation. Pediatr Pulmonol 14:102-109
17. Wolfson MR, Shaffer TH 1990 Liquid ventilation during early development: theory, physiologic processes and application. J Dev Physiol 13:1-12
18. Wolfson MR, Greenspan JS, Shaffer TH 1998 Liquid-assisted ventilation: an alternative respiratory modality. Pediatr Pulmonol 26:42-63
19. Cullen AB, Cox CA, Hipp SJ, Wolfson MR, Shaffer TH 1999 Intratracheal delivery of gentamicin with partial liquid ventilation. Respir Med 93:770-778
20. Wolfson MR, Greenspan JS, Shaffer TH 1996 Pulmonary administration of vasoactive substances by perfluorochemical ventilation. Pediatrics 97:449-455
21. Al-Rahmani A, Awad K, Miller TF, Wolfson MR, Shaffer TH 2000 Effects of partial liquid ventilation with perfluorodecalin in the juvenile rabbit lung after saline injury. Crit Care Med 28:1459-464
22. Jeng MJ, Trevisanuto D, Weis CM, Fox WW, Cullen AB, Wolfson MR, Shaffer TH 2001 Role of ventilation strategy on perfluorochemical evaporation from the lungs. J Appl Physiol 90:1365-1372
23. Mazzoni M, Nugent L, Klein D, Hoffman J, Sekins KM, Flaim SF 1999 Dose monitoring in partial liquid ventilation by infrared measurement of expired perfluorochemicals. Biomed Instrum Technol 33:356-364
24. Shaffer TH, Foust R, Wolfson MR, Miller TF 1997 Analysis of perfluorochemical elimination from the respiratory system. J Appl Physiol 83:1033-1040
25. Tütüncü AS, Faithfull NS, Lachmann B 1993 Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with respiratory failure. Am Rev Respir Dis 148:785-792
26. Wolfson MR, Greenspan JS, Deoras KS, Rubenstein SD, Shaffer TH 1992 Comparison of gas and liquid ventilation: clinical, physiological and histological correlates. J Appl Physiol 72:1024-1031
27. Jeng M-J, Yang S-S, Wolfson MR, Shaffer TH 2003 Perfluorochemical (PFC) combinations for acute lung injury: an in vitro and in vivo study in juvenile rabbits. Pediatr Res 53:81-88
28. Boynton BR, Carlo WA, Jobe AH 1994 New Therapies for Neonatal Respiratory Failure. Cambridge University Press, New York, p 185
29. Notter RH, Egan EA, Kwong MS, Holm BA, Shapiro DL 1985 Lung surfactant replacement in premature lambs with extracted lipid from bovine lung lavage: effect of dose, dispersion technique, and gestational age. Pediatr Res 19:569-577
30. Fox WW, Weis CM, Cox C, Farina C, Drott H, Wolfson MR, Shaffer TH 1997 Pulmonary administration of gentamicin during liquid ventilation in a newborn lamb lung injury model. Pediatrics 100:E5
31. Wolfson, MR Kechner, NE Roache, RF DeChadarevian, J-P Friss, HE Rubenstein, SD Shaffer, TH 1998 Perfluorochemical rescue after surfactant treatment: effect of perflubron dose and ventilatory frequency. J Appl Physiol 84:624-640
32. Forman HJ, Torres M 2002 Reactive oxygen species and cell signaling. Am J Respir Crit Care Med 166:S4-S8
33. Crapo JD, DeLong DM, Sjostrom K, Hasler GR, Drew RT 1977 The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. Am Rev Respir Dis 115:1027-1033
34. Padmanabhan RV, Gudapaty R, Liener IE, Schwartz BA, Hoidal JR 1985 Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am Rev Respir Dis 132:164-167
35. Turrens JF, Crapo JD, Freeman BA 1984 Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 73:87-95
36. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A 1993 Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 74:2234-2241
37. Das S, Horowitz S, Robbins CG, el-Sabban ME, Sahgal N, Davis JM 1998 Intracellular uptake of recombinant superoxide dismutase after intratracheal administration. Am J Physiol 274:L673-L677
38. Langenback EG, Davis JM, Robbins C, Sahgal N, Perry RJ, Simon SR 1999 Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizer. Pediatr Pulmonol 27:124-129
39. Slutsky AS, Tremblay LN 1998 Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 157:1721-1725
40. Kinnula VL, Crapo JD 2003 Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 167:1600-1619
41. Jankov RP, Negus A, Tanswell AK 2001 Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 50:681-687
42. Nathan C 2003 Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 111:769-778